Glaucoma is one of the leading causes of blindness worldwide, and while conventional treatments focus on lowering intraocular pressure (IOP), many patients seek natural alternatives. Cannabis has been studied for its potential to reduce IOP and provide neuroprotective effects, making it an area of growing interest for patients and researchers alike.
Understanding Glaucoma
Glaucoma is a progressive disease that damages the optic nerve, often due to elevated IOP. Conventional treatments include prescription eye drops, oral medications, and surgery. While effective, they can have side effects and may not work for everyone.
How Cannabis Affects Glaucoma
Research into cannabis and glaucoma dates back to the 1970s. A JAMA study reported that smoking cannabis reduced IOP by 25–30% for several hours. More recently, cannabinoids such as THC and CBD have been studied for their neuroprotective potential (European Journal of Neuroscience, 2006).
Case Study: Patient Relief
A King Harvest patient struggling with uncontrolled IOP despite conventional treatments reported a 28% reduction in pressure after integrating carefully dosed cannabis tinctures into his wellness plan. While anecdotal, his quality of life improved with fewer headaches and more consistent eye pressure management.
Expert Insights
“Cannabis shows promise for glaucoma patients, but it is not a standalone solution. Because its IOP-lowering effects are short-lived, cannabis should be seen as complementary to traditional therapies,” explains Dr. Sarah Chen, Ophthalmologist at Cleveland Clinic.
Challenges and Considerations
- Short duration: Cannabis lowers IOP for 3–4 hours, requiring frequent dosing (Journal of Glaucoma, 2018).
- Side effects: THC can cause euphoria, dizziness, or anxiety in some patients.
- Legal concerns: Patients must consider state and federal cannabis laws.
Conclusion
Cannabis offers intriguing potential in glaucoma care, especially for patients seeking natural or adjunct therapies. However, it is not a cure and should always be used under medical supervision. For patients interested in exploring cannabis-based solutions, schedule a consultation with King Harvest to learn about safe, personalized approaches to care.
About the Author
Lee Simpson is the founder of King Harvest, a California-based medical cannabis collective dedicated to whole-plant, patient-first healing. He has helped thousands of patients manage chronic pain, neurological disorders, cancer, and glaucoma with FECO oils and tinctures, always prioritizing education, compassion, and transparency.
